Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02556710 · ClinicalTrials.gov registry record · Phase 3
A Study to Evaluate the Efficacy & Safety of an Intra-Articular Ampion Injection for Pain of Osteoarthritis of the Knee
A Phase 3 study, sponsored by Ampio Pharmaceuticals..
- Completed
- Registry status
- Phase 3
- Development phase
- 480
- Enrollment target
NCT02556710: Completed Phase 3 study, sponsored by Ampio Pharmaceuticals..
NCT02556710 is a Phase 3 study that has completed, run by Ampio Pharmaceuticals.. The registered enrollment target is 480 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (38% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02556710, a Phase 3 study, has completed, sponsored by Ampio Pharmaceuticals..
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 480 participants
- Enrollment target
Study Summary
This study will evaluate the efficacy and safety of an intra-articular injection of AMPION™ in adults with pain due to osteoarthritis of the knee
Primary Outcome
Mean Change in WOMAC A Pain (Western Ontario and McMaster Universities Arthritis Index) score from Baseline to 12 weeks. 5-point Likert scale (0=none to 4=extreme). A negative difference constitutes a decrease in pain with a greater negative value indicating a greater reduction in pain.
Interventions
- DRUG 4 mL injection of Placebo
- BIOLOGICAL 4 mL injection of AMPION™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 480 participants |
| Start Date | 2015-09 |
| Est. Completion | 2016-06 |
| Phase | Phase 3 |
What the finished NCT02556710 record still lists
NCT02556710 is an interventional study that assigns participants to a tested intervention. The registered 480 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (38% lower).
The record links to 0 conditions, and to 2 interventions - of which 4 mL injection of Placebo is the first listed.
NCT02556710 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02556710 about?
NCT02556710 is a clinical study titled "A Study to Evaluate the Efficacy & Safety of an Intra-Articular Ampion Injection for Pain of Osteoarthritis of the Knee". This study will evaluate the efficacy and safety of an intra-articular injection of AMPION™ in adults with pain due to osteoarthritis of the knee
What is the current status of trial NCT02556710?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 480 participants. The study started on 2015-09. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02556710?
The interventions under investigation include: 4 mL injection of Placebo (DRUG), 4 mL injection of AMPION™ (BIOLOGICAL).
Who is sponsoring clinical trial NCT02556710?
This trial is sponsored by Ampio Pharmaceuticals., which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02556710's enrollment target sits among peer trials
480 792nd of 2000 higher than 1,197 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01954992 · 480 participants · Phase 3
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
- NCT03023696 · 480 participants · NA
Can Prophylactic Foraminotomy Prevent C5 Palsy
- NCT04948060 · 480 participants · NA
Tribally Engaged Approaches to Lung Screening (TEALS)
- NCT05053230 · 480 participants · NA
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia